Acid suppression in patients with GERD declines after 2 years' continuous PPI treatment

被引：0

|

作者：

机构：

来源：

Nature Clinical Practice Gastroenterology & Hepatology | 2007年 / 4卷 / 7期

关键词：

D O I：

10.1038/ncpgasthep0830

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：359 / 359

相关论文

共 50 条

[1] Patients with GERD and Not Barretts Show Normalized Impedance After PPI Treatment
Roberts, Jason
Banerjee, Promila
Freeman, Janice
Castell, Donald O.
GASTROENTEROLOGY, 2009, 136 (05) : A594 - A594
[2] It Is Difficult to Discontinue PPI Treatment in Patients With GERD
Bjornsson, Einar
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (02): : 367 - 368
[3] Eleven years' experience of continuous maintenance treatment with omeprazole in GERD-patients.
Klinkenberg-Knol, EC
GASTROENTEROLOGY, 1998, 114 (04) : A180 - A180
[4] Symptoms Reported by Patients With GERD With a Partial Symptomatic Response to PPI Treatment
Niklasson, Anna
Karlsson, Maria
GASTROENTEROLOGY, 2011, 140 (05) : S581 - S581
[5] Treatment of Bile Reflux Phenotype Improved Response to Treatment in PPI Refractory GERD Patients
Tabbaa, Mumtaz
Di Stante, Alex
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S449 - S450
[6] THE OPTIMAL TIMING TO MODIFY THE TREATMENT FOR THE SYMPTOMATIC GERD PATIENTS REFRACTORY TO PPI THERAPY
Nakada, Koji
Matsuhashi, Nobuyuki
Joh, Takashi
Higuchi, Kazuhide
Iwakiri, Katsuhiko
Haruma, Ken
GASTROENTEROLOGY, 2017, 152 (05) : S467 - S467
[7] Beyond acid suppression: New pharmacologic approaches for treatment of gerd
Kuo P.
Holloway R.H.
Current Gastroenterology Reports, 2010, 12 (3) : 175 - 180
[8] Clinical outcome after laparoscopic Nissen fundoplication in patients with GERD and PPI refractory heartburn
Schwameis, Katrin
Oh, Daniel
Green, Kyle M.
Lin, Brenda
Zehetner, Joerg
Lipham, John C.
Hagen, Jeffrey A.
DeMeester, Steven R.
DISEASES OF THE ESOPHAGUS, 2020, 33 (04)
[9] Safety of long-term treatment with a new PPI, esomeprazole in GERD patients.
Genta, RM
Magner, DJ
D'Amico, D
Levine, DS
GASTROENTEROLOGY, 2000, 118 (04) : A16 - A16
[10] CYP2C19 pharmacogenetics in PPI therapy of GERD:: Variant alleles predict gastric acid suppression, but not esophageal acid exposure or reflux symptoms
Egan, LJ
Myhre, G
Mays, D
Kammer, P
Dierkhising, R
Murray, JA
GASTROENTEROLOGY, 2003, 124 (04) : A109 - A109

← 1 2 3 4 5 →